The radiotherapy devices market size has grown strongly in recent years. It will grow from $6.64 billion in 2025 to $7.21 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to rising global cancer incidence rates, expansion of oncology treatment infrastructure, increasing adoption of external beam radiation therapies, improvements in linear accelerator performance, wider availability of advanced radiotherapy techniques.
The radiotherapy devices market size is expected to see strong growth in the next few years. It will grow to $10.18 billion in 2030 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to growing demand for personalized cancer treatment, increasing investments in proton therapy centers, expansion of AI-assisted oncology workflows, rising focus on minimizing radiation side effects, continued technological innovation in radiation delivery systems. Major trends in the forecast period include increasing adoption of image-guided radiation therapy systems, rising deployment of proton therapy technologies, growing integration of ai-based treatment planning, expansion of stereotactic radiation techniques, enhanced focus on precision dose delivery.
The rising prevalence of cancer is anticipated to drive the growth of the radiotherapy devices market in the future. Cancer prevalence refers to the total number or proportion of individuals within a population diagnosed with cancer at a specific point in time or over a defined period. Radiotherapy is frequently used as a primary or supportive treatment for newly diagnosed cancer patients. It is employed to shrink tumors, control cancer progression, or destroy cancer cells before or after surgical procedures. For example, in July 2024, the Australian Institute of Health and Welfare, an Australian government agency, reported that the number of cancer cases diagnosed in Australia increased from 160,570 in 2022 to 164,694 in 2023, marking a significant annual rise. This trend underscores the growing prevalence of cancer in the country. Consequently, the increasing prevalence of cancer is driving the demand for radiotherapy devices.
Major companies operating in the radiotherapy devices market are actively innovating new technologies such as The Versa HD to enhance their market profitability. The Versa HD is a linear accelerator system designed for radiation therapy. For instance, in May 2023, the Mitchell Cancer Institute introduced a new radiation technology known as The Versa HD. This system is capable of delivering Volumetric Modulated Arc Therapy (VMAT), which accelerates treatment delivery and enhances the patient's experience. The Versa HD also provides High-Definition Dynamic Radiosurgery (HDRS), equipped with special sequencing capabilities, effectively transforming the linear accelerator into a specialized solution for Stereotactic Radiosurgery (SRS).
In October 2023, Elekta, a Sweden-based provider of radiotherapy devices and oncology treatment solutions, acquired the Xoft Axxent electronic brachytherapy (eBx) system from iCAD, Inc. for $5.5 million. Through this acquisition, Elekta sought to broaden its brachytherapy portfolio and increase the adoption of electronic X-ray-based brachytherapy systems in markets with limited radiation shielding infrastructure. iCAD, Inc. is a US-based company that manufactures radiotherapy devices.
Major companies operating in the radiotherapy devices market are Varian Medical Systems Inc., Elekta AB, Accuray Incorporated, IBA Ion Beam Applications SA, Koninklijke Philips N.V., Siemens Aktiengesellschaft, Eckert & Ziegler Bebig, IsoRay Inc., General Electric Healthcare, Vision RT Ltd., RaySearch Laboratories AB, Theragenics Corporation, Canon Medical Systems Corporation, Mitsubishi Electric Corporation, Shinva Medical Instrument Company Limited, Neusoft Medical Systems Co. Ltd., Mevion Medical Systems Inc., Optivus Proton Therapy Inc., Panacea Medical Technologies Pvt. Ltd., P-Cure Ltd., Provision Healthcare LLC, Sumitomo Heavy Industries Ltd., ViewRay Inc., Miranda Medical, Nordion Inc., NTP Radioisotopes SOC Ltd., Curium, Hitachi Ltd., Brainlab AG, Best Theratronics Ltd., ProTom International Inc., RefleXion Medical Inc., Insightec Ltd., TomoTherapy Incorporated, Agile MV LLC, CIVCO Radiotherapy, Johari Digital Healthcare Ltd., Alpha Tau Medical Ltd.,
North America was the largest region in the radiotherapy devices market in 2025. Asia-Pacific was the second-largest region in the global radiotherapy devices market report. The regions covered in the radiotherapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the radiotherapy devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are impacting the radiotherapy devices market by increasing costs of imported linear accelerators, imaging components, precision sensors, control software, and shielding materials used in advanced radiation systems. Hospitals and oncology centers in North America and Europe are most affected due to reliance on imported high-value medical equipment, while Asia-Pacific faces higher procurement costs for advanced treatment installations. These tariffs are raising capital expenditure requirements and extending procurement timelines. However, they are also encouraging localized manufacturing, regional assembly partnerships, and domestic innovation in radiotherapy device development.
The radiotherapy devices market research report is one of a series of new reports that provides radiotherapy devices market statistics, including radiotherapy devices industry global market size, regional shares, competitors with a radiotherapy devices market share, detailed radiotherapy devices market segments, market trends and opportunities, and any further data you may need to thrive in the radiotherapy devices industry. This radiotherapy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Radiotherapy devices are utilized in cancer treatment by delivering high doses of radiation to eliminate cancer cells and reduce tumor size. These devices are designed to target and destroy cancerous cells while minimizing harm to the surrounding healthy tissues. Through techniques such as external beam radiation and brachytherapy, radiotherapy devices play an essential role in the treatment and management of cancer.
The primary product types of radiotherapy devices include external beam radiation therapy devices, linear accelerator devices (LINAC), and proton therapy devices. A medical linear accelerator, or LINAC, is a radiotherapy device typically employed for external beam radiation treatments in cancer patients. It delivers high-energy x-rays or electrons to the specific region of the patient's tumor. These devices find applications in treating various types of cancer, including skin cancer, breast cancer, prostate cancer, cervical cancer, lung cancer, and others. Radiotherapy devices are used in healthcare settings such as hospitals, ambulatory surgical centers, and oncological treatment centers.
The radiotherapy devices market consists of sales of external beam radiation therapy devices, linear accelerator devices, and proton therapy devices that are used for radiotherapy. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The radiotherapy devices market size is expected to see strong growth in the next few years. It will grow to $10.18 billion in 2030 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to growing demand for personalized cancer treatment, increasing investments in proton therapy centers, expansion of AI-assisted oncology workflows, rising focus on minimizing radiation side effects, continued technological innovation in radiation delivery systems. Major trends in the forecast period include increasing adoption of image-guided radiation therapy systems, rising deployment of proton therapy technologies, growing integration of ai-based treatment planning, expansion of stereotactic radiation techniques, enhanced focus on precision dose delivery.
The rising prevalence of cancer is anticipated to drive the growth of the radiotherapy devices market in the future. Cancer prevalence refers to the total number or proportion of individuals within a population diagnosed with cancer at a specific point in time or over a defined period. Radiotherapy is frequently used as a primary or supportive treatment for newly diagnosed cancer patients. It is employed to shrink tumors, control cancer progression, or destroy cancer cells before or after surgical procedures. For example, in July 2024, the Australian Institute of Health and Welfare, an Australian government agency, reported that the number of cancer cases diagnosed in Australia increased from 160,570 in 2022 to 164,694 in 2023, marking a significant annual rise. This trend underscores the growing prevalence of cancer in the country. Consequently, the increasing prevalence of cancer is driving the demand for radiotherapy devices.
Major companies operating in the radiotherapy devices market are actively innovating new technologies such as The Versa HD to enhance their market profitability. The Versa HD is a linear accelerator system designed for radiation therapy. For instance, in May 2023, the Mitchell Cancer Institute introduced a new radiation technology known as The Versa HD. This system is capable of delivering Volumetric Modulated Arc Therapy (VMAT), which accelerates treatment delivery and enhances the patient's experience. The Versa HD also provides High-Definition Dynamic Radiosurgery (HDRS), equipped with special sequencing capabilities, effectively transforming the linear accelerator into a specialized solution for Stereotactic Radiosurgery (SRS).
In October 2023, Elekta, a Sweden-based provider of radiotherapy devices and oncology treatment solutions, acquired the Xoft Axxent electronic brachytherapy (eBx) system from iCAD, Inc. for $5.5 million. Through this acquisition, Elekta sought to broaden its brachytherapy portfolio and increase the adoption of electronic X-ray-based brachytherapy systems in markets with limited radiation shielding infrastructure. iCAD, Inc. is a US-based company that manufactures radiotherapy devices.
Major companies operating in the radiotherapy devices market are Varian Medical Systems Inc., Elekta AB, Accuray Incorporated, IBA Ion Beam Applications SA, Koninklijke Philips N.V., Siemens Aktiengesellschaft, Eckert & Ziegler Bebig, IsoRay Inc., General Electric Healthcare, Vision RT Ltd., RaySearch Laboratories AB, Theragenics Corporation, Canon Medical Systems Corporation, Mitsubishi Electric Corporation, Shinva Medical Instrument Company Limited, Neusoft Medical Systems Co. Ltd., Mevion Medical Systems Inc., Optivus Proton Therapy Inc., Panacea Medical Technologies Pvt. Ltd., P-Cure Ltd., Provision Healthcare LLC, Sumitomo Heavy Industries Ltd., ViewRay Inc., Miranda Medical, Nordion Inc., NTP Radioisotopes SOC Ltd., Curium, Hitachi Ltd., Brainlab AG, Best Theratronics Ltd., ProTom International Inc., RefleXion Medical Inc., Insightec Ltd., TomoTherapy Incorporated, Agile MV LLC, CIVCO Radiotherapy, Johari Digital Healthcare Ltd., Alpha Tau Medical Ltd.,
North America was the largest region in the radiotherapy devices market in 2025. Asia-Pacific was the second-largest region in the global radiotherapy devices market report. The regions covered in the radiotherapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the radiotherapy devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are impacting the radiotherapy devices market by increasing costs of imported linear accelerators, imaging components, precision sensors, control software, and shielding materials used in advanced radiation systems. Hospitals and oncology centers in North America and Europe are most affected due to reliance on imported high-value medical equipment, while Asia-Pacific faces higher procurement costs for advanced treatment installations. These tariffs are raising capital expenditure requirements and extending procurement timelines. However, they are also encouraging localized manufacturing, regional assembly partnerships, and domestic innovation in radiotherapy device development.
The radiotherapy devices market research report is one of a series of new reports that provides radiotherapy devices market statistics, including radiotherapy devices industry global market size, regional shares, competitors with a radiotherapy devices market share, detailed radiotherapy devices market segments, market trends and opportunities, and any further data you may need to thrive in the radiotherapy devices industry. This radiotherapy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Radiotherapy devices are utilized in cancer treatment by delivering high doses of radiation to eliminate cancer cells and reduce tumor size. These devices are designed to target and destroy cancerous cells while minimizing harm to the surrounding healthy tissues. Through techniques such as external beam radiation and brachytherapy, radiotherapy devices play an essential role in the treatment and management of cancer.
The primary product types of radiotherapy devices include external beam radiation therapy devices, linear accelerator devices (LINAC), and proton therapy devices. A medical linear accelerator, or LINAC, is a radiotherapy device typically employed for external beam radiation treatments in cancer patients. It delivers high-energy x-rays or electrons to the specific region of the patient's tumor. These devices find applications in treating various types of cancer, including skin cancer, breast cancer, prostate cancer, cervical cancer, lung cancer, and others. Radiotherapy devices are used in healthcare settings such as hospitals, ambulatory surgical centers, and oncological treatment centers.
The radiotherapy devices market consists of sales of external beam radiation therapy devices, linear accelerator devices, and proton therapy devices that are used for radiotherapy. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Radiotherapy Devices Market Characteristics
3. Radiotherapy Devices Market Supply Chain Analysis
4. Global Radiotherapy Devices Market Trends and Strategies
5. Radiotherapy Devices Market Analysis of End Use Industries
7. Global Radiotherapy Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Radiotherapy Devices Total Addressable Market (TAM) Analysis for the Market
9. Radiotherapy Devices Market Segmentation
10. Radiotherapy Devices Market Regional and Country Analysis
11. Asia-Pacific Radiotherapy Devices Market
12. China Radiotherapy Devices Market
13. India Radiotherapy Devices Market
14. Japan Radiotherapy Devices Market
15. Australia Radiotherapy Devices Market
16. Indonesia Radiotherapy Devices Market
17. South Korea Radiotherapy Devices Market
18. Bangladesh Radiotherapy Devices Market
19. Thailand Radiotherapy Devices Market
20. Vietnam Radiotherapy Devices Market
21. Malaysia Radiotherapy Devices Market
22. Singapore Radiotherapy Devices Market
23. Philippines Radiotherapy Devices Market
24. Hong Kong Radiotherapy Devices Market
25. New Zealand Radiotherapy Devices Market
26. Taiwan Radiotherapy Devices Market
27. South East Asia Radiotherapy Devices Market
28. Western Europe Radiotherapy Devices Market
29. UK Radiotherapy Devices Market
30. Germany Radiotherapy Devices Market
31. France Radiotherapy Devices Market
32. Italy Radiotherapy Devices Market
33. Spain Radiotherapy Devices Market
34. Austria Radiotherapy Devices Market
35. Belgium Radiotherapy Devices Market
36. Denmark Radiotherapy Devices Market
37. Finland Radiotherapy Devices Market
38. Ireland Radiotherapy Devices Market
39. Netherlands Radiotherapy Devices Market
40. Norway Radiotherapy Devices Market
41. Portugal Radiotherapy Devices Market
42. Sweden Radiotherapy Devices Market
42. Switzerland Radiotherapy Devices Market
43. Eastern Europe Radiotherapy Devices Market
44. Russia Radiotherapy Devices Market
45. Czech Republic Radiotherapy Devices Market
46. Poland Radiotherapy Devices Market
47. Romania Radiotherapy Devices Market
48. Ukraine Radiotherapy Devices Market
49. North America Radiotherapy Devices Market
50. USA Radiotherapy Devices Market
51. Canada Radiotherapy Devices Market
52. Mexico Radiotherapy Devices Market
53. South America Radiotherapy Devices Market
54. Brazil Radiotherapy Devices Market
55. Chile Radiotherapy Devices Market
56. Argentina Radiotherapy Devices Market
57. Colombia Radiotherapy Devices Market
58. Peru Radiotherapy Devices Market
59. Middle East Radiotherapy Devices Market
60. Saudi Arabia Radiotherapy Devices Market
61. Israel Radiotherapy Devices Market
62. Iran Radiotherapy Devices Market
63. Turkey Radiotherapy Devices Market
64. United Arab Emirates Radiotherapy Devices Market
65. Africa Radiotherapy Devices Market
66. Egypt Radiotherapy Devices Market
67. Nigeria Radiotherapy Devices Market
68. South Africa Radiotherapy Devices Market
70. Radiotherapy Devices Market Competitive Landscape and Company Profiles
71. Radiotherapy Devices Market Other Major and Innovative Companies
74. Radiotherapy Devices Market High Potential Countries, Segments and Strategies
75. Appendix
List of Tables
Executive Summary
Radiotherapy Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses radiotherapy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for radiotherapy devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The radiotherapy devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: External Beam Radiation Therapy Devices; Linear Accelerator Devices; Proton Therapy Devices2) By Application: Skin Cancer; Breast Cancer; Prostate Cancer; Cervical Cancer; Lung Cancer; Other Applications
3) By End Users: Hospitals; Ambulatory Surgical Centers; Oncological Treatment Centers
Subsegments:
1) By External Beam Radiation Therapy Devices: Intensity-Modulated Radiation Therapy (IMRT) Devices; Image-Guided Radiation Therapy (IGRT) Devices; Stereotactic Body Radiation Therapy (SBRT) Devices; Stereotactic Radiosurgery (SRS) Devices; 3D Conformal Radiation Therapy (3D CRT) Devices2) By Linear Accelerator Devices: Conventional Linear Accelerators; Stereotactic Linear Accelerators
3) By Proton Therapy Devices: Cyclotron-Based Devices; Synchrotron-Based Devices; Synchrocyclotron-Based Devices
Companies Mentioned: Varian Medical Systems Inc.; Elekta AB; Accuray Incorporated; IBA Ion Beam Applications SA; Koninklijke Philips N.V.; Siemens Aktiengesellschaft; Eckert & Ziegler Bebig; IsoRay Inc.; General Electric Healthcare; Vision RT Ltd.; RaySearch Laboratories AB; Theragenics Corporation; Canon Medical Systems Corporation; Mitsubishi Electric Corporation; Shinva Medical Instrument Company Limited; Neusoft Medical Systems Co. Ltd.; Mevion Medical Systems Inc.; Optivus Proton Therapy Inc.; Panacea Medical Technologies Pvt. Ltd.; P-Cure Ltd.; Provision Healthcare LLC; Sumitomo Heavy Industries Ltd.; ViewRay Inc.; Miranda Medical; Nordion Inc.; NTP Radioisotopes SOC Ltd.; Curium; Hitachi Ltd.; Brainlab AG; Best Theratronics Ltd.; ProTom International Inc.; RefleXion Medical Inc.; Insightec Ltd.; TomoTherapy Incorporated; Agile MV LLC; CIVCO Radiotherapy; Johari Digital Healthcare Ltd.; Alpha Tau Medical Ltd.;
Countries: China; India; Japan; Australia; Indonesia; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; Taiwan; New Zealand; UK; Germany; France; Italy; Spain; Austria; Belgium; Denmark; Finland; Ireland; Netherlands; Norway; Portugal; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Radiotherapy Devices market report include:- Varian Medical Systems Inc.
- Elekta AB
- Accuray Incorporated
- IBA Ion Beam Applications SA
- Koninklijke Philips N.V.
- Siemens Aktiengesellschaft
- Eckert & Ziegler Bebig
- IsoRay Inc.
- General Electric Healthcare
- Vision RT Ltd.
- RaySearch Laboratories AB
- Theragenics Corporation
- Canon Medical Systems Corporation
- Mitsubishi Electric Corporation
- Shinva Medical Instrument Company Limited
- Neusoft Medical Systems Co. Ltd.
- Mevion Medical Systems Inc.
- Optivus Proton Therapy Inc.
- Panacea Medical Technologies Pvt. Ltd.
- P-Cure Ltd.
- Provision Healthcare LLC
- Sumitomo Heavy Industries Ltd.
- ViewRay Inc.
- Miranda Medical
- Nordion Inc.
- NTP Radioisotopes SOC Ltd.
- Curium
- Hitachi Ltd.
- Brainlab AG
- Best Theratronics Ltd.
- ProTom International Inc.
- RefleXion Medical Inc.
- Insightec Ltd.
- TomoTherapy Incorporated
- Agile MV LLC
- CIVCO Radiotherapy
- Johari Digital Healthcare Ltd.
- Alpha Tau Medical Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 7.21 Billion |
| Forecasted Market Value ( USD | $ 10.18 Billion |
| Compound Annual Growth Rate | 9.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 39 |
